Cited by 168Phytoestrogen effects and researchPhytochemicals and Antioxidant ActivitiesEstrogen and related hormone effects

Risks and benefits of dietary isoflavones for cancer

Andres, Susanne, Abraham, Klaus, Appel, Klaus Erich, Lampen, Alfonso·2011·Critical Reviews in Toxicology

Abstract

A high intake of fruits and vegetables is associated with a lower risk of cancer. In this context, considerable attention is paid to Asian populations who consume high amounts of soy and soy-derived isoflavones, and have a lower risk for several cancer types such as breast and prostate cancers than populations in Western countries. Hence, interest focuses on soyfoods, soy products, and soy ingredients such as isoflavones with regard to their possible beneficial effects that were observed in numerous experiments and studies. The outcomes of the studies are not always conclusive, are often contradictory depending on the experimental conditions, and are, therefore, difficult to interpret. Isoflavone research revealed not only beneficial but also adverse effects, for instance, on the reproductive system. This is also the case with tumor-promoting effects on, for example, breast tissue. Isoflavone extracts and supplements are often used for the treatment of menopausal symptoms and for the prevention of age-associated conditions such as cardiovascular diseases and osteoporosis in postmenopausal women. In relation to this, questions about the effectiveness and safety of isoflavones have to be clarified. Moreover, there are concerns about the maternal consumption of isoflavones due to the development of leukemia in infants. In contrast, men may benefit from the intake of isoflavones with regard to reducing the risk of prostate cancer. Therefore, this review examines the risks but als…

Integrity signals

Registry

Crossref · 10.3109/10408444.2010.541900

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Andres, S., Abraham, K., Appel, K. E., & Lampen, A.
Affiliations
German Federal Institute for Risk Assessment (BfR) (DE)
Corresponding author
Lampen, Alfonso
Venue
Critical Reviews in Toxicology
Published
2011-03-26
Volume
41
Issue
6
Pages
463-506
ISSN
  • 0045-6446 (ISSN-L)
  • 1040-8444
  • 1547-6898
OpenAlex
W2126228623
Cited by
168
References
3
Citations by year
2026: 1 · 2025: 4 · 2024: 6 · 2023: 6 · 2022: 5 · 2021: 10 · 2020: 6 · 2019: 5 · 2018: 9 · 2017: 13 · 2016: 18 · 2015: 23 · 2014: 18 · 2013: 19 · 2012: 19
FWCI
2.49
Type
journal article
Language
en
Open access
closed
Locations
  • Critical Reviews in Toxicology (publishedVersion)
  • PubMed (publishedVersion)
  • OpenAgrar (submittedVersion)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Phytoestrogen effects and research
  • Health Sciences › Medicine › Biochemistry › Phytochemicals and Antioxidant Activities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
Keywords
isoflavones, soy products, cancer risk, breast cancer, prostate cancer, tumor promotion, reproductive toxicity, menopausal symptoms, osteoporosis, cardiovascular disease, infant leukemia, Asian populations, dietary phytoestrogens
MeSH terms
Animals, Biological Availability, Carcinogens, Cardiovascular Diseases, Diet, Disease Models, Animal, Drug Combinations, Female, Humans, Isoflavones, Male, Phytotherapy, Neoplasms, Plant Extracts, Glycine max, Carcinogenicity Tests, Osteoporosis, Postmenopausal, Anticarcinogenic Agents, Risk Assessment, Hormone Replacement Therapy, Phytoestrogens

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review